N. Hirshoren, K. Kaganov, J.M. Weinberger, B. Glaser, B. Uziely, I. Mizrahi et al. Thyroidectomy practice after implementation of the 2015 American Thyroid Association Guidelines on surgical options for patients with well-differentiated thyroid carcinoma. JAMA Otolaryngol. Head Neck Surg. 144(5), 427–432 (2018)

Article  PubMed  PubMed Central  Google Scholar 

S. Chan, K. Karamali, A. Kolodziejczyk, G. Oikonomou, J. Watkinson, V. Paleri, I. Nixon, D. Kim, Systematic review of recurrence rate after hemithyroidectomy for low-risk well-differentiated thyroid cancer. Eur. Thyroid J. 9(2), 12 (2020).

Article  Google Scholar 

D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16(2), 109–142 (2006)

Article  PubMed  Google Scholar 

R.M. Tuttle, A.S. Alzahrani, Risk stratification in differentiated thyroid cancer: from detection to final follow-up. J. Clin. Endocrinol. Metab. 104(9), 4087–4100 (2019)

B.M. Barney, Y.J. Hitchcock, P. Sharma, D.C. Shrieve, J.D. Tward, Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck 33(5), 645–649 (2011)

Article  PubMed  Google Scholar 

B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)

Article  PubMed  PubMed Central  Google Scholar 

E. Song, M. Han, H.S. Oh, W.W. Kim, M.J. Jeon, Y.M. Lee et al. Lobectomy is feasible for 1–4 cm papillary thyroid carcinomas: a 10-year propensity score matched-pair analysis on recurrence. Thyroid 29(1), 64–70 (2019)

Article  PubMed  Google Scholar 

D. Matsuura, A. Yuan, V. Harris, A.R. Shaha, R.M. Tuttle, S.G. Patel et al. Surgical management of low-/intermediate-risk node negative thyroid cancer: a single-institution study using propensity matching analysis to compare thyroid lobectomy and total thyroidectomy. Thyroid 32(1), 28–36 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R.M. Tuttle, Controversial issues in thyroid cancer management. J. Nucl. Med. 59(8), 1187–1194 (2018)

Article  PubMed  PubMed Central  Google Scholar 

I.J. Nixon, I. Ganly, S. Patel, F.L. Palmer, M.M. Whitcher, R.M. Tuttle et al. The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. Surgery 150(6), 1242–1249 (2011)

Article  PubMed  Google Scholar 

F. Vaisman, D. Momesso, D.A. Bulzico, C.H. Pessoa, M.D. da Cruz, F. Dias et al. Thyroid lobectomy is associated with excellent clinical outcomes in properly selected differentiated thyroid cancer patients with primary tumors greater than 1 cm. J. Thyroid Res. 2013, 398194 (2013)

Article  PubMed  PubMed Central  Google Scholar 

M. Zerey, A.S. Prabhu, W.L. Newcomb, A.E. Lincourt, K.W. Kercher, B.T. Heniford, Short-term outcomes after unilateral versus complete thyroidectomy for malignancy: a national perspective. Am. Surg. 75(1), 20–24 (2009)

Article  PubMed  Google Scholar 

A. Hauch, Z. Al-Qurayshi, G. Randolph, E. Kandil, Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons. Ann. Surg. Oncol. 21(12), 3844–3852 (2014)

Article  PubMed  Google Scholar 

P.W. Rosario, G.F. Mourão, M.R. Calsolari, Apparently intrathyroid papillary thyroid carcinoma >1 and ≤4 cm: is the need for completion thyroidectomy common among patients submitted to lobectomy? Clin. Endocrinol. 85(1), 150–151 (2016)

Article  Google Scholar 

R. Olmos, J. Lopez, F. Donoso, M. Ruiz-Esquide, T. Zegers, L. Mosso et al. Management of thyroid nodules and thyroid cancer with lobectomy: experience of a multidisciplinary team. Rev. Chil. Endocrinol. Diabetes 13(3), 118–124 (2020)

Google Scholar 

D.P. Momesso, F. Vaisman, S.P. Yang, D.A. Bulzico, R. Corbo, M. Vaisman et al. Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine. J. Clin. Endocrinol. Metab. 101(7), 2692–2700 (2016)

Article  CAS  PubMed  PubMed Central  Google Scholar 

L.F. Zavala, M.I. Barra, R. Olmos, M. Tuttle, H. González, N. Droppelmann et al. In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation. Arch. Endocrinol. Metab. 63(3), 293–299 (2019)

PubMed  PubMed Central  Google Scholar 

S. Leboulleux, M.J. Schlumberger, I. Borget, Thyroidectomy without radioiodine in low-risk thyroid cancer. Reply. N. Engl. J. Med. 386(22), 2155 (2022)

PubMed  Google Scholar 

I.J. Nixon, I. Ganly, S.G. Patel, F.L. Palmer, M.M. Whitcher, R.M. Tuttle et al. Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery 151(4), 571–579 (2012)

Article  PubMed  Google Scholar 

F. Vaisman, A. Shaha, S. Fish, R. Michael Tuttle, Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer. Clin. Endocrinol. 75(1), 112–119 (2011)

Article  CAS  Google Scholar 

W.P. Kluijfhout, J.D. Pasternak, F.T. Drake, T. Beninato, W.T. Shen, J.E. Gosnell et al. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine. Surgery 161(1), 127–133 (2017)

Article  PubMed  Google Scholar 

Z. Al-Qurayshi, M.A. Shama, G.W. Randolph, E. Kandil, Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer. Endocr. Relat. Cancer 24(5), 221–226 (2017)

Article  PubMed  Google Scholar 

R.S.R. Woods, C.W.R. Fitzgerald, C. Valero, J. Lopez, L.G.T. Morris, M.A. Cohen et al. Surgical management of T1/T2 node-negative papillary thyroid cancer with tall cell histology: is lobectomy enough? Surgery 173(1), 246–251 (2023)

Article  PubMed  Google Scholar 

G.W. Randolph, Q.Y. Duh, K.S. Heller, V.A. LiVolsi, S.J. Mandel, D.L. Steward et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22(11), 1144–1152 (2012)

Article  PubMed  Google Scholar 

M.J. Jeon, J.H. Yoon, J.M. Han, J.H. Yim, S.J. Hong, D.E. Song et al. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Eur. J. Endocrinol. 168(2), 219–225 (2013)

Article  CAS  PubMed  Google Scholar 

D. Beom Heo, Y. Piao, J. Hee Lee, S.H. Ju, H.S. Yi, M. Su Kim et al. Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis. Oral Oncol. 134, 106115 (2022)

Article  PubMed  Google Scholar 

C. Durante, T. Montesano, M. Attard, M. Torlontano, F. Monzani, G. Costante et al. Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement? J. Clin. Endocrinol. Metab. 97(8), 2748–2753 (2012)

Article  CAS  PubMed  Google Scholar 

K.Y. Bilimoria, D.J. Bentrem, C.Y. Ko, A.K. Stewart, D.P. Winchester, M.S. Talamonti et al. Extent of surgery affects survival for papillary thyroid cancer. Ann. Surg. 246(3), 375–381 (2007).

Article  PubMed  PubMed Central  Google Scholar 

I.D. Hay, C.S. Grant, E.J. Bergstralh, G.B. Thompson, J.A. van Heerden, J.R. Goellner, Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 124(6), 958–964 (1998).

Article  CAS  PubMed  Google Scholar 

Y.J. Li, Y.Z. Wang, Z.B. Yi, L.L. Chen, X.D. Zhou, Comparison of completion thyroidectomy and primary total surgery for differentiated thyroid cancer: a meta-analysis. Oncol. Res. Treat. 38(10), 528–531 (2015)

Article  PubMed  Google Scholar 

M.A. Gulcelik, L. Dogan, G.G. Akgul, E.H. Güven, N. Ersöz Gulcelik, Completion thyroidectomy: safer than thought. Oncol. Res. Treat. 41(6), 386–390 (2018)

Article  PubMed  Google Scholar 

P.W. Rosário, T.A. Fagundes, S. Purisch, [Treatment of papillary microcarcinoma of the thyroid]. Arq. Bras. Endocrinol. Metabol. 48(6), 855–860 (2004)

Article  PubMed  Google Scholar 

S. Xu, H. Huang, X. Zhang, Y. Huang, B. Guan, J. Qian et al. Predictive value of serum thyroglobulin for structural recurrence following lobectomy for papillary thyroid carcinoma. Thyroid 31(9), 1391–1399 (2021)

Article  CAS